X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
0
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-6-2020-1588742806.pdf
https://www.pharmacompass.com/pdf/news/health-canada-issues-recall-of-pendopharm-division-of-pharmasciences-axid-1588660442.pdf
https://www.fiercepharma.com/manufacturing/amneal-yanks-nazitidine-solution-off-u-s-shelves-fears-possible-carcinogen
https://www.pharmacompass.com/pdf/news/amneal-pharmaceuticalsissues-voluntary-nationwide-recall-of-nizatidine-oral-solution-1587446824.pdf
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-29-2020-1580279088.pdf
https://www.in-pharmatechnologist.com/Article/2020/01/09/Mylan-recalls-batches-of-nizatidine-over-NDMA-impurity
https://www.pharmacompass.com/pdf/news/mylan-initiates-voluntary-nationwide-recall-of-three-lots-of-nizatidine-capsules-1578746489.pdf
https://www.fiercepharma.com/pharma/stop-and-plan-it-out-sanofi-ceo-paul-hudson-has-some-tips-for-pharma-s-technology-ambitions
https://www.thehindubusinessline.com/markets/stock-markets/solara-active-pharma-sciences/article30525304.ece
https://www.prnewswire.com/news-releases/mylan-initiates-voluntary-nationwide-recall-of-three-lots-of-nizatidine-capsules-usp-due-to-the-detection-of-trace-amounts-of-ndma-n-nitrosodimethylamine-impurity-found-in-the-active-pharmaceutical-ingredient-manufactured-by-s-300983578.html
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/solara-active-pharma-to-conduct-internal-probe-on-nizatidine-api-amid-mylan-recall/articleshow/73167327.cms
https://www.prnewswire.com/news-releases/mylan-initiates-voluntary-nationwide-recall-of-three-lots-of-nizatidine-capsules-usp-due-to-the-detection-of-trace-amounts-of-ndma-n-nitrosodimethylamine-impurity-found-in-the-active-pharmaceutical-ingredient-manufactured-by-s-300983578.html
https://www.prnewswire.com/news-releases/mylan-initiates-voluntary-nationwide-recall-of-three-lots-of-nizatidine-capsules-usp-due-to-the-detection-of-trace-amounts-of-ndma-n-nitrosodimethylamine-impurity-found-in-the-active-pharmaceutical-ingredient-manufactured-by-s-300983578.html
https://www.business-standard.com/article/news-cm/solara-active-pharma-sciences-update-on-ranitidine-hydrochloride-nizatidine-api-119110400595_1.html
https://www.business-standard.com/article/news-cm/solara-active-pharma-sciences-update-on-ranitidine-hydrochloride-nizatidine-api-119110400595_1.html
https://www.raps.org/news-and-articles/news-articles/2019/10/fda-explains-levels-of-impurity-found-in-recalled
https://www.thehindubusinessline.com/markets/stock-markets/solara-active-pharma-science/article28321934.ece
http://www.prnewswire.com/news-releases/viiv-healthcare-announces-phase-ii-study-results-for-first-two-drug-long-acting-injectable-regimen-for-hiv-1-treatment-569850931.html
Market Place
Share 
